Quarterly report pursuant to Section 13 or 15(d)

Document and Entity Information

Document and Entity Information - shares
3 Months Ended
Jul. 31, 2019
Sep. 12, 2019
Document And Entity Information [Abstract]    
Entity Registrant Name PharmaCyte Biotech, Inc.  
Entity Central Index Key 0001157075  
Document Type 10-Q  
Document Period End Date Jul. 31, 2019  
Amendment Flag false  
Current Fiscal Year End Date --04-30  
Entity Filer Category Non-accelerated Filer  
Entity Common Stock, Shares Outstanding   1,328,171,172
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2020  
Entity Current Reporting Status Yes  
Entity Emerging Growth false  
Entity Small Business true  
Interactive Data Current? Yes  
Incorporation State NV  
Entity File Number 333-68008